Products - Diabetes | Topic | NICE

Showing 29 products

Date | Sort by Title

Product type: GuidanceRemove ‘Product type: Guidance’ filter
Status: PublishedRemove ‘Status: Published’ filter

Diabetes in pregnancy: management from preconception to the postnatal period (NG3)
Product type:
Guidance
Programme:
NICE guideline
Last updated:
16 December 2020
Published date:
25 February 2015
Diabetes (type 1 and type 2) in children and young people: diagnosis and management (NG18)
Product type:
Guidance
Programme:
NICE guideline
Last updated:
16 December 2020
Published date:
1 August 2015
Type 1 diabetes in adults: diagnosis and management (NG17)
Product type:
Guidance
Programme:
NICE guideline
Last updated:
16 December 2020
Published date:
26 August 2015
Type 2 diabetes in adults: management (NG28)
Product type:
Guidance
Programme:
NICE guideline
Last updated:
16 December 2020
Published date:
2 December 2015
Ranibizumab for treating diabetic retinopathy (terminated appraisal) (TA637)
Product type:
Guidance
Programme:
Technology appraisal guidance
Published date:
30 June 2020
Sotagliflozin with insulin for treating type 1 diabetes (TA622)
Product type:
Guidance
Programme:
Technology appraisal guidance
Published date:
12 February 2020
Dapagliflozin with insulin for treating type 1 diabetes (TA597)
Product type:
Guidance
Programme:
Technology appraisal guidance
Last updated:
12 February 2020
Published date:
28 August 2019
Fluocinolone acetonide intravitreal implant for treating chronic diabetic macular oedema in phakic eyes after an inadequate response to previous therapy (TA613)
Product type:
Guidance
Programme:
Technology appraisal guidance
Published date:
20 November 2019
Diabetic foot problems: prevention and management (NG19)
Product type:
Guidance
Programme:
NICE guideline
Last updated:
11 October 2019
Published date:
26 August 2015
Ertugliflozin with metformin and a dipeptidyl peptidase-4 inhibitor for treating type 2 diabetes (TA583)
Product type:
Guidance
Programme:
Technology appraisal guidance
Published date:
5 June 2019
Ertugliflozin as monotherapy or with metformin for treating type 2 diabetes (TA572)
Product type:
Guidance
Programme:
Technology appraisal guidance
Published date:
27 March 2019
The Debrisoft monofilament debridement pad for use in acute or chronic wounds (MTG17)
Product type:
Guidance
Programme:
Medical technologies guidance
Last updated:
25 March 2019
Published date:
25 March 2014
Type 2 diabetes: prevention in people at high risk (PH38)
Product type:
Guidance
Programme:
Public health guideline
Last updated:
15 September 2017
Published date:
12 July 2012
Dapagliflozin in combination therapy for treating type 2 diabetes (TA288)
Product type:
Guidance
Programme:
Technology appraisal guidance
Last updated:
23 November 2016
Published date:
26 June 2013
Dapagliflozin in triple therapy for treating type 2 diabetes (TA418)
Product type:
Guidance
Programme:
Technology appraisal guidance
Published date:
23 November 2016
Canagliflozin, dapagliflozin and empagliflozin as monotherapies for treating type 2 diabetes (TA390)
Product type:
Guidance
Programme:
Technology appraisal guidance
Published date:
25 May 2016
Integrated sensor-augmented pump therapy systems for managing blood glucose levels in type 1 diabetes (the MiniMed Paradigm Veo system and the Vibe and G4 PLATINUM CGM system) (DG21)
Product type:
Guidance
Programme:
Diagnostics guidance
Published date:
12 February 2016
Aflibercept for treating diabetic macular oedema (TA346)
Product type:
Guidance
Programme:
Technology appraisal guidance
Published date:
22 July 2015
Dexamethasone intravitreal implant for treating diabetic macular oedema (TA349)
Product type:
Guidance
Programme:
Technology appraisal guidance
Published date:
22 July 2015
Implantation of a duodenal–jejunal bypass liner for managing type 2 diabetes (IPG518)
Product type:
Guidance
Programme:
Interventional procedures guidance
Published date:
27 March 2015
Empagliflozin in combination therapy for treating type 2 diabetes (TA336)
Product type:
Guidance
Programme:
Technology appraisal guidance
Published date:
25 March 2015
VibraTip for testing vibration perception to detect diabetic peripheral neuropathy (MTG22)
Product type:
Guidance
Programme:
Medical technologies guidance
Last updated:
1 March 2015
Published date:
31 December 2014
Canagliflozin in combination therapy for treating type 2 diabetes (TA315)
Product type:
Guidance
Programme:
Technology appraisal guidance
Published date:
25 June 2014
Fluocinolone acetonide intravitreal implant for treating chronic diabetic macular oedema after an inadequate response to prior therapy (TA301)
Product type:
Guidance
Programme:
Technology appraisal guidance
Published date:
27 November 2013
Ranibizumab for treating diabetic macular oedema (TA274)
Product type:
Guidance
Programme:
Technology appraisal guidance
Published date:
27 February 2013
Type 2 diabetes prevention: population and community-level interventions (PH35)
Product type:
Guidance
Programme:
Public health guideline
Published date:
10 May 2011
Autologous pancreatic islet cell transplantation for improved glycaemic control after pancreatectomy (IPG274)
Product type:
Guidance
Programme:
Interventional procedures guidance
Published date:
24 September 2008
Continuous subcutaneous insulin infusion for the treatment of diabetes mellitus (TA151)
Product type:
Guidance
Programme:
Technology appraisal guidance
Published date:
23 July 2008
Allogeneic pancreatic islet cell transplantation for type 1 diabetes mellitus (IPG257)
Product type:
Guidance
Programme:
Interventional procedures guidance
Published date:
23 April 2008